TuisOPL • ASX
add
Opyl Ltd
Vorige sluiting
$0,019
Jaarwisseling
$0,014 - $0,033
Markkapitalisasie
2,75 m AUD
Gemiddelde volume
110,33 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
ASX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (AUD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 167,72 k | 37,65% |
Bedryfskoste | 323,38 k | 42,41% |
Netto inkomste | -341,60 k | 46,47% |
Netto winsgrens | -203,67 | 61,11% |
Wins per aandeel | — | — |
EBITDA | -318,04 k | 25,38% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (AUD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 329,55 k | -43,64% |
Totale bates | 384,82 k | -41,63% |
Totale aanspreeklikheid | 695,82 k | -3,76% |
Totale ekwiteit | -310,99 k | — |
Uitstaande aandele | 170,80 m | — |
Prys om te bespreek | ∞ | — |
Opbrengs op bates | -208,46% | — |
Opbrengs op kapitaal | -683,20% | — |
Kontantvloei
Netto kontantverandering
| (AUD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -341,60 k | 46,47% |
Kontant van bedrywe | -309,99 k | -6,88% |
Kontant van beleggings | -662,00 | — |
Kontant van finansiering | 288,10 k | -19,06% |
Netto kontantverandering | -22,55 k | -134,21% |
Beskikbare kontantvloei | -200,74 k | 18,01% |
Meer oor
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Gestig
2013
Webwerf
Werknemers
3
